Delivery Order SPE2DE24DA010-SPE2D626F166V
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $14,850 on November 14, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by November 19, 2025, and will be performed in Santa Clara, California. The award represents a child contract under Abbott Laboratories Inc.'s broader federal contracting portfolio and was made...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $24,350 by the Defense Logistics Agency's Medical Supply Chain on November 14, 2025, with an ultimate completion date of November 19, 2025. The delivery order, which carries no set-aside designation, will be performed in Santa Clara, California. This award represents a task order issued under Abbott's existing $117.1 million Indefinite Delivery Contract with the Defense...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $9,500 by the Defense Logistics Agency's Medical Supply Chain on November 14, 2025, with an ultimate completion date of November 19, 2025. The contract utilizes a fixed-price structure with economic price adjustment provisions and carries no set-aside designation, reflecting full and open competition. This delivery order represents a discrete procurement action under Abbott Vascular's...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $37,164.80 by the Medical Supply Chain division of the Department of Defense on June 18, 2025, with a completion date of June 24, 2025. The award is designated as a fixed-price contract with economic price adjustment and was issued without a set-aside, indicating full and open competition. Performance will be executed at Abbott's facility in Santa Clara, California. This delivery order...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $11,750 on November 4, 2025, by the Defense Logistics Agency's Medical Supply Chain for cardiovascular medical devices and related technologies. The contract, which is not set-aside and operates under a fixed-price structure with economic price adjustment provisions, is scheduled for completion by November 7, 2025, with performance taking place in Santa Clara, California. This delivery...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order (Contract No. 4569302326) valued at $9,243.00 by the Defense Logistics Agency's Medical Supply Chain on August 21, 2025, with an ultimate completion date of September 8, 2025. The contract utilizes fixed-price pricing with economic price adjustment and does not include a set-aside designation, indicating full and open competition. Performance will take place in Santa Clara, California. This delivery...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a delivery order valued at $22,780.00 by the Medical Supply Chain division of the Department of Defense. This fixed-price delivery order with economic price adjustment was issued on September 16, 2025, with an ultimate completion date of September 19, 2025, and will be performed in Santa Clara, California. The award was made under full and open competition with no set-aside designation. The delivery order...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $39,422.80 fixed-price delivery order (Contract 4570007649, GALLANT) by the Defense Logistics Agency's Medical Supply Chain on November 14, 2025, with completion scheduled for November 19, 2025. This delivery order, which carries no set-aside designation, represents a task order issued against Abbott's broader $117.1 million Indefinite Delivery Contract with the Defense Logistics Agency for comprehensive...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a fixed-price delivery order valued at $5,695.00 by the Defense Logistics Agency's Medical Supply Chain division. The contract, issued on May 20, 2025, with an ultimate completion date of June 9, 2025, represents a child contract under Abbott Laboratories Inc.'s parent entity and will be performed in Santa Clara, California. This delivery order was awarded without a set-aside designation, indicating full and...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a fixed-price delivery order valued at $5,695.00 by the Medical Supply Chain division of the Department of Defense. The contract, awarded on May 30, 2025, with an ultimate completion date of June 4, 2025, represents a delivery order under a larger indefinite delivery vehicle. This award was made through full and open competition with no set-aside designation. The place of performance is Santa Clara, California....
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D626F166VDelivery Order
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $9,203.00 by the Defense Logistics Agency's Medical Supply Chain on November 14, 2025, with an ultimate completion date of November 19, 2025. This fixed-price contract with economic price adjustment carries no set-aside designation and represents a child delivery order issued against a larger indefinite delivery vehicle. The place of performance is Santa Clara, California, reflecting Abbott Vascular's established operational presence in the region and its role as a critical supplier of cardiovascular medical technologies to federal healthcare systems. This delivery order aligns with Abbott Laboratories' substantial federal contracting portfolio supporting the Defense Logistics Agency's Medical Supply Chain, which has historically generated numerous task orders for cardiovascular procedural packages, devices, instrumentation, and accessories. Abbott Vascular's federal engagement focuses primarily on providing advanced cardiovascular technologies including stents, heart valves, pacemakers, and specialized surgical implants to support complex medical procedures across military and veteran healthcare networks. The award demonstrates Abbott's continued competitive positioning in full and open competition mechanisms within federal medical device procurement, leveraging the company's established indefinite delivery contracts and its recognized expertise in delivering integrated procedural support to federal healthcare agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.2k | 11/14/25 |